Literature DB >> 11808095

Thymic carcinoma successfully resected with superior vena cava after chemoradiotherapy.

Y Shintani1, M Ohta, K Hazama, S Miyoshi, K Kagisaki, H Matsuda.   

Abstract

A 57-year-old woman hospitalized for thymic cancer invading the superior vena cava and left brachiocephalic vein evidenced both pleural and pericardial effusion. After chemotherapy with cisplatin and docetaxel and concurrent radiotherapy, the entire tumor was successfully resected along with the pericardium, superior vena cava, and left brachiocephalic vein, followed by vascular reconstruction. Pathologically, viable tumor cells were identified only in the center of the tumor as anaplastic cell carcinoma. Induction chemoradiotherapy thus appears useful in enabling complete resection of advanced thymic carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11808095     DOI: 10.1007/bf02913512

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  9 in total

1.  Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.

Authors:  J Zalcberg; M Millward; J Bishop; M McKeage; A Zimet; G Toner; M Friedlander; C Barter; D Rischin; C Loret; R James; N Bougan; J Berille
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

2.  Thymic carcinoma treated with intensive chemotherapy and radiation.

Authors:  H Yanagawa; H Bando; Y Takishita; Y Suzuki; F Kohrai; M Takahashi
Journal:  Anticancer Res       Date:  1995 Jul-Aug       Impact factor: 2.480

Review 3.  Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy.

Authors:  R W Carlson; R F Dorfman; B I Sikic
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

4.  The surgical treatment of invasive thymoma. Resection with vascular reconstruction.

Authors:  N Shimizu; S Moriyama; M Aoe; M Nakata; A Ando; S Teramoto
Journal:  J Thorac Cardiovasc Surg       Date:  1992-03       Impact factor: 5.209

5.  [Complete resection of thymic carcinoma supported by cardiopulmonary bypass].

Authors:  S Fujino; T Nojima; S Asakura; M Onoe; S Watarida; A Mori
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1991-08

6.  Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded.

Authors:  K Yagi; T Hirata; T Fukuse; H Yokomise; K Inui; O Ike; H Mizuno; M Aoki; S Hitomi; H Wada
Journal:  Ann Thorac Surg       Date:  1996-02       Impact factor: 4.330

7.  A tentative tumor-node-metastasis classification of thymoma.

Authors:  Y Yamakawa; A Masaoka; T Hashimoto; H Niwa; T Mizuno; Y Fujii; K Nakahara
Journal:  Cancer       Date:  1991-11-01       Impact factor: 6.860

8.  Undifferentiated epithelial-rich invasive malignant thymoma: complete response to cisplatin, vinblastine, and bleomycin therapy.

Authors:  C Dy; F A Calvo; J P Mindán; L A Aparicio; S M Algarra; A Gil; F González; S Harguindey
Journal:  J Clin Oncol       Date:  1988-03       Impact factor: 44.544

9.  Thymic carcinoma. A clinicopathologic study of 60 cases.

Authors:  S Suster; J Rosai
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

  9 in total
  1 in total

1.  Multimodality treatment for advanced thymic carcinoma: outcomes of induction therapy followed by surgical resection in 16 cases at a single institution.

Authors:  Yasushi Shintani; Masayoshi Inoue; Tomohiro Kawamura; Soichiro Funaki; Masato Minami; Meinoshin Okumura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-10-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.